@prefix : <http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#1b8a27ba-ab68-43ab-8c72-eab5573103e7>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#f66d4f90-50f9-4548-b7c5-8b9f9d808a43>
	rdf:type pr:Epoch ;
	isoC:label "Supportive Care | Exercise-led Phase"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#663933c0-a62c-4d24-b108-d92de58cadb8>
	rdf:type pr:Epoch ;
	isoC:label "Follow-Up | Home-based Phase"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#ead646a3-0554-4875-b1a3-3bdfc43e8c43>
	rdf:type pr:Arm ;
	isoC:label "rtCGM"^^xsd:string ;
	pr:description "Real-time Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#425ed2cb-3cc8-4904-b8ec-a33c2d2f6fd1>
	rdf:type pr:Arm ;
	isoC:label "isCGM"^^xsd:string ;
	pr:description "Intermittent scan (flash) Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#3bd4bd11-2f08-427a-ac46-753d76e2f20f>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#ead646a3-0554-4875-b1a3-3bdfc43e8c43> ;
	pr:inEpoch <http://www.assero.co.uk/EP#1b8a27ba-ab68-43ab-8c72-eab5573103e7> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
.
<http://www.assero.co.uk/ELE#25086f44-628b-48b9-8fa1-330d3d1b934b>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#425ed2cb-3cc8-4904-b8ec-a33c2d2f6fd1> ;
	pr:inEpoch <http://www.assero.co.uk/EP#f66d4f90-50f9-4548-b7c5-8b9f9d808a43> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
.
<http://www.assero.co.uk/ELE#e7e6c5d2-c4fb-48f2-883c-cb0ed23f9e61>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#ead646a3-0554-4875-b1a3-3bdfc43e8c43> ;
	pr:inEpoch <http://www.assero.co.uk/EP#f66d4f90-50f9-4548-b7c5-8b9f9d808a43> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#e9e40118-fdad-45e8-871f-01d769716ff3> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a> ;
.
<http://www.assero.co.uk/ELE#c46cd816-8fba-485c-8d77-34504850def0>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#425ed2cb-3cc8-4904-b8ec-a33c2d2f6fd1> ;
	pr:inEpoch <http://www.assero.co.uk/EP#f66d4f90-50f9-4548-b7c5-8b9f9d808a43> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#e9e40118-fdad-45e8-871f-01d769716ff3> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a> ;
.
<http://www.assero.co.uk/ELE#1a888ba6-be7a-4267-9b75-5ebd213ad88f>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#ead646a3-0554-4875-b1a3-3bdfc43e8c43> ;
	pr:inEpoch <http://www.assero.co.uk/EP#663933c0-a62c-4d24-b108-d92de58cadb8> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
<http://www.assero.co.uk/ELE#81733904-5655-40b1-8f9c-e3b4d815b0b0>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#425ed2cb-3cc8-4904-b8ec-a33c2d2f6fd1> ;
	pr:inEpoch <http://www.assero.co.uk/EP#663933c0-a62c-4d24-b108-d92de58cadb8> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZINVESTDEV Type 2 Diabetes"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T07:10:46+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZINVESTDEV T2"^^xsd:string ;
	pr:title "The aim of this investigator's study is to compare real-time continuous glucose monitoring (rtCGM) and flash glucose monitoring (isCGM) in adult patients with Type 1 or Type 2 Diabetes during a 14-day training program focused on physical activity and over 4 or 6 weeks of follow-up at home"^^xsd:string ;
	pr:shortTitle "ZINVESTDEV"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#ead646a3-0554-4875-b1a3-3bdfc43e8c43> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#425ed2cb-3cc8-4904-b8ec-a33c2d2f6fd1> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#1b8a27ba-ab68-43ab-8c72-eab5573103e7> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#f66d4f90-50f9-4548-b7c5-8b9f9d808a43> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#663933c0-a62c-4d24-b108-d92de58cadb8> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#377a510b-9b9a-44af-99e6-d1d0394f49a1> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#8c9d0aa6-7021-4757-9444-a75b3d4385b7> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#f277e022-e61f-4166-bb5d-4b378f63611f> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#75114cd7-2f62-4685-be35-8ab6bd546cec> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZINVESTDEV T2DM"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V38#C66737_C48660> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V55#C99076_C82639> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Run-in"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 2"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_8726b7bc-c176-4da8-8edd-326e94db57c1> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#5b757f1f-1b8a-43b1-8b44-b86550b2e160> ;
.
<http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_48419ba1-bc1a-4245-8818-ceab4848092a> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#626a53ea-6849-45ed-9dc3-3f45109384fd> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#635ff048-b2e2-4fd6-aeb3-10392cb228dc> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#dd6bc927-6cfc-46f7-9060-aaed0e26b50e> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#d53d7c99-4340-4241-a369-64111013af6d> ;
.
<http://www.assero.co.uk/TP#e9e40118-fdad-45e8-871f-01d769716ff3>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_65fdf1d9-e48e-4df0-a7be-b01d5f03d72e> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#c1968aad-e787-471d-be1f-0f44e6df1fc7> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#dc949211-5cce-41e2-a540-913c38b8d488> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#d06c3ab5-c042-4e20-ad61-d45552ec47dd> ;
.
<http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_86e21b16-17b4-4d03-a8ea-3413d2210271> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#16035dd5-285d-4f91-8817-b064d1bc556f> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#13780f79-2eb6-479c-a3de-fda6c33af69f> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#06321cd3-ede8-4e18-9d00-7713fbfe31bc> ;
.
<http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_272819a9-60e8-48b6-98d3-24241385fc0e> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#3cb36a0b-5af4-41b5-b4f2-b3b55e4af8f7> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#c65dd43f-4ddc-4dac-a7e0-1a7eb867663e> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#3ea511af-b633-48c5-9f48-08f732d4fafe> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#96e1473f-f91f-4d9e-a85c-c03f544b1231> ;
.
<http://www.assero.co.uk/IC#TPO_8726b7bc-c176-4da8-8edd-326e94db57c1>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "-604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_48419ba1-bc1a-4245-8818-ceab4848092a>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_65fdf1d9-e48e-4df0-a7be-b01d5f03d72e>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "4233600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_86e21b16-17b4-4d03-a8ea-3413d2210271>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "8467200"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_272819a9-60e8-48b6-98d3-24241385fc0e>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "25401600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#377a510b-9b9a-44af-99e6-d1d0394f49a1>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#884f92ba-40b3-4c0d-884a-35b6205fe6bd> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#3e83ac4c-d047-4a6f-909d-023899ddeed5> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#8c9d0aa6-7021-4757-9444-a75b3d4385b7>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#8b2b506a-fec6-4c05-b39e-f4febcdac4ea> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#f277e022-e61f-4166-bb5d-4b378f63611f>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#7bd3d5a9-0f00-47de-9a10-7bd1d645146e> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#4306282a-66b7-430d-ab29-a41c3f682500> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#fb04fdf9-b505-411f-8948-3bc593199ad0> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#96157f1a-456b-48e5-9ef5-77a4dd0e1fb1> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#75114cd7-2f62-4685-be35-8ab6bd546cec>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#e643d71c-a4cb-4baa-9d35-b9d0d6497814> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#419e99e0-bff9-402d-8d0c-77f90ab07595>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#4679deae-7e6c-47eb-8e3a-de34db6b4700> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#884f92ba-40b3-4c0d-884a-35b6205fe6bd>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
<http://www.assero.co.uk/PREND#3e83ac4c-d047-4a6f-909d-023899ddeed5>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
<http://www.assero.co.uk/PREND#8b2b506a-fec6-4c05-b39e-f4febcdac4ea>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
.
<http://www.assero.co.uk/PREND#7bd3d5a9-0f00-47de-9a10-7bd1d645146e>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
<http://www.assero.co.uk/PREND#4306282a-66b7-430d-ab29-a41c3f682500>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#e9e40118-fdad-45e8-871f-01d769716ff3> ;
.
<http://www.assero.co.uk/PREND#fb04fdf9-b505-411f-8948-3bc593199ad0>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#e9e40118-fdad-45e8-871f-01d769716ff3> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#274975e8-95ca-464c-a79c-cd3c3fa9cf9a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#6d3de1ed-b9e5-4ea9-829b-4832c529c9a7> ;
.
<http://www.assero.co.uk/PREND#96157f1a-456b-48e5-9ef5-77a4dd0e1fb1>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
.
<http://www.assero.co.uk/PREND#e643d71c-a4cb-4baa-9d35-b9d0d6497814>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
.
<http://www.assero.co.uk/PREND#4679deae-7e6c-47eb-8e3a-de34db6b4700>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#89ce5a10-c59a-416d-8590-991940da3afc> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#ff8e0d5e-ff76-45ca-9b9b-5dfcdb93d49e> ;
.
<http://www.assero.co.uk/STFRM#5b757f1f-1b8a-43b1-8b44-b86550b2e160>
	rdf:type pr:StudyForm ;
	isoC:label "Informed Consent"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/INFORMED_CONSENT_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#626a53ea-6849-45ed-9dc3-3f45109384fd>
	rdf:type pr:StudyForm ;
	isoC:label "Device Allocation"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/DEVICE_ALLOC_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#635ff048-b2e2-4fd6-aeb3-10392cb228dc>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#dd6bc927-6cfc-46f7-9060-aaed0e26b50e>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#d53d7c99-4340-4241-a369-64111013af6d>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#c1968aad-e787-471d-be1f-0f44e6df1fc7>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#dc949211-5cce-41e2-a540-913c38b8d488>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#d06c3ab5-c042-4e20-ad61-d45552ec47dd>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#16035dd5-285d-4f91-8817-b064d1bc556f>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#13780f79-2eb6-479c-a3de-fda6c33af69f>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#06321cd3-ede8-4e18-9d00-7713fbfe31bc>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#3cb36a0b-5af4-41b5-b4f2-b3b55e4af8f7>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#c65dd43f-4ddc-4dac-a7e0-1a7eb867663e>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#3ea511af-b633-48c5-9f48-08f732d4fafe>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#96e1473f-f91f-4d9e-a85c-c03f544b1231>
	rdf:type pr:StudyForm ;
	isoC:label "Termination Record"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/TERMINATION_DEMO/V1#F> ;
.